Literature DB >> 22125935

WHO disability grade does not influence physical activity in Brazilian leprosy patients.

Glauber Dias Do Prado1, Renata Bilion Ruiz Prado, Lúcia Helena Soares Camargo Marciano, Susilene Maria Tonelli Nardi, José Antonio Cordeiro, Henrique Luiz Monteiro.   

Abstract

Disability caused by leprosy may be associated with stigma. The aim of this work is to describe the degree of disability, quality of life and level of physical activity of individuals with leprosy and to identify possible correlations between these factors. Ninety-seven patients from two referral centres were studied. A complete medical history was taken and the World Health Organization degree of physical disability classification (WHO-DG), the International Physical Activity Questionnaire (IPAQ) and the Medical Outcome Study 36-item Short-form health Survey (SF36) were applied. The mean age of patients was 51 +/- 14.9 years old; participants were predominantly men, married, unemployed, had concluded treatment and had had lepromatous leprosy. The WHO-DG and the level of physical activity (P-value = 0.36) were not correlated. The WHO-DG showed that 72.2% of patients had disabilities, 37.1% of whom performed vigorous physical activities. No significant association was observed between the WHO-DG and the domains of the QoL SF-36 except for functional capacity (P-value = 0.02); the physical capacity is generally 'very good' when individuals have no disabilities and 'bad' with severe disabilities. In conclusion, the WHO-DG of leprosy patients does not affect the level of physica activities or quality of life except functional capacity. There is no significan association between physical activities and quality of life in these individuals.

Entities:  

Mesh:

Year:  2011        PMID: 22125935

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  4 in total

1.  Patients' perceptions on the performance of a local health system to eliminate leprosy,Paraná State, Brazil.

Authors:  Flávia Meneguetti Pieri; Michelle Mosna Touso; Ludmila Barbosa Bandeira Rodrigues; Mellina Yamamura; Ione Carvalho Pinto; Elma Mathias Dessunti; Juliane de Almeida Crispim; Antônio Carlos Vieira Ramos; Luiz Henrique Arroyo; Marcelino Santos Neto; Maria Concebida da Cunha Garcia; Marcela Paschoal Popolin; Tatiane Ramos dos Santos Silveira; Ricardo Alexandre Arcêncio
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

2.  Psychometric assessment of the EMIC Stigma Scale for Brazilians affected by leprosy.

Authors:  Fabiane Frota da Rocha Morgado; Erika Maria Kopp Xavier da Silveira; Lilian Pinheiro Rodrigues do Nascimento; Anna Maria Sales; José Augusto da Costa Nery; Euzenir Nunes Sarno; Ximena Illarramendi
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

3.  Revised estimates of leprosy disability weights for assessing the global burden of disease: A systematic review and individual patient data meta-analysis.

Authors:  Shri Lak Nanjan Chandran; Anuj Tiwari; Anselmo Alves Lustosa; Betul Demir; Bob Bowers; Rachel Gimenes Rodrigues Albuquerque; Renata Bilion Ruiz Prado; Saba Lambert; Hiroyuki Watanabe; Juanita Haagsma; Jan Hendrik Richardus
Journal:  PLoS Negl Trop Dis       Date:  2021-03-02

4.  A Quality of Life Study in Patients with Leprosy Using DLQI and WHOQOL-BREF Questionnaires.

Authors:  Dakshata A Tare; Vishalakshi Viswanath; Kalpita S Pai; Dinesh R Samel
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.